Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 21 |
|---|
Dr. Damon R. Reed, MD is an oncologist in New York, NY specializing in oncology (cancer care) and hematology (blood disorders). He graduated from Case Western Reserve University School of Medicine. Dr. Damon R. Reed, MD is affiliated with Memorial Sloan Kettering Cancer Center, MEMORIAL PEDIATRIC GROUP, MEMORIAL SOLID TUMOR GROUP and Memorial Sloan Kettering Cancer Center.
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 21 |
|---|
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 52 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 19 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 55 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| Non-Hispanic White | 12 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 24 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 38 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 34 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 29 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 20 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 29 |
|---|
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 31 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 18 |
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 15 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 31 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 15 |
Volume of procedures performed by Dr. Damon R. Reed, MD for Medicare patients.
| doctor visit | 35 |
|---|
Information about Medicare patients treated by Dr. Damon R. Reed, MD.
| Black / African American | 0 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 1 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 0 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 16 |
| 65 to 74 | 0 |
Dr. Damon R. Reed, MD graduated from Case Western Reserve University School of Medicine. He completed residency at Children's Hospital Boston. He is certified by the Board Certification: Pediatric Hematology/Oncology and has a state license in Tennessee.
Medical School: Case Western Reserve University School of Medicine
Residency: Children's Hospital Boston
Board Certification: Board Certification: Pediatric Hematology/Oncology
Licensed In: Tennessee
Dr. Damon R. Reed, MD appears to accept the following insurance providers: Magnacare, Carrum Health, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, UMR, MVP, Emblem Essential, Husky CT Medicaid, Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO), NYC Medicare Advantage Plus for City Employees, World Trade Center Health Program (WTC), Emblem Medicare Advantage, Oscar, First Health, Qualcare, Horizon Medicare Advantage, Aetna, Blue Cross Health Plus, Emblem, Healthfirst, Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan), Blue Cross Blue Shield states outside of NY/NJ, Tricare, Healthfirst Managed Medicaid, Fidelis, Multiplan/Beech Street/PHCS, Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23), United Healthcare, Medicare Part A&B (traditional Medicare), Horizon Blue Cross Blue Shield New Jersey (PPO), Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO), Blue Cross Blue Shield Federal Employee Program, Connecticare, Oxford, Straight NJ Medicaid, Horizon Blue Cross Blue Shield New Jersey (HMO), Healthsmart, Empire Essential, Straight NY Medicaid, Healthfirst Medicare Advantage, Fidelis Medicare Advantage, Cigna, Empire Blue Cross Medicare Advantage and Fidelis Managed Medicaid & HARP.
According to our sources, Dr. Damon R. Reed, MD accepts the following insurance providers:
Dr. Damon R. Reed, MD has an exceptional overall rating with an average of 4.86 out of 5 stars based on 59 ratings. We collect ratings and reviews of Dr. Damon R. Reed, MD from all over the web to help you find the right in New York, NY.
These charts describe general payments received by Dr. Damon R. Reed, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| EMD Serono, Inc. |
$5,449
$5,449 |
||||
|---|---|---|---|---|---|
| RECORDATI_RARE_DISEASES_INC. |
$5,406
$5,406 |
||||
| Janssen Products, LP |
$3,684
YONDELIS $3,684 |
||||
| EISAI INC. |
$1,875
Lenvima $1,875 |
||||
| Shire North American Group Inc |
$1,670
Oncaspar $1,670 |
||||
| Other |
$2,284
Research $500 |
GMRS $144 |
VOTRIENT $125 |
Erwinaze $115 |
$1,400 |
| Consulting Fee | $17,965 |
|---|---|
| Food and Beverage | $1,365 |
| Travel and Lodging | $1,037 |
Dr. Damon R. Reed, MD has received 311 research payments totaling $355,179.
I am a pediatric hematologist-oncologist on the MSK Kids team at Memorial Sloan Kettering Cancer Care. I specialize in the care of children, adolescents, and young adults with sarcomas and other solid tumors. I have particular expertise and interest in studying the changes that happen in tumors to make them resistant to therapies.